Page last updated: 2024-08-21

alpha-aminopyridine and Skin Neoplasms

alpha-aminopyridine has been researched along with Skin Neoplasms in 16 studies

Research

Studies (16)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's11 (68.75)24.3611
2020's5 (31.25)2.80

Authors

AuthorsStudies
Wei, C; Zhang, W; Zhang, Y; Zhou, DB1
Blackham, A; Box, J; Demberger, L; Federowicz, B; Friedland, JC; Ginn, S; Horton, M; Knoerzer, D; McIntosh, A; Nair, S; Shapiro, M; Sheikh, H; Stuhlmiller, TJ; Wolfe, Z1
Aasen, SN; Bjerkvig, R; Feng, Z; Hoang, T; Knappskog, S; Parajuli, H; Roy, K; Stokke, K; Thorsen, F; Wang, J1
Aplin, AE; Chervoneva, I; Erkes, DA; Field, CO; Rosenbaum, SR; Villanueva, J1
Chai, J; Li, M; Li, Z; Liu, X; Mi, J; Qin, H; Wu, J; Xu, J1
Afghani, S; Ai, WZ; Balassanian, R; Bandyopadhyay, S; Gao, HX; Gill, R; McCormick, F; Moasser, M; Pincus, L; Rakhshandehroo, T; Rubenstein, J; Wang, L; Wu, CH; Yang, CY1
Brotherton, R; Chang, ALS; Moffat, A; Pague, A; Tran, DC; Zhu, GA1
Aptullahoglu, E; Esfandiari, A; Ho, YH; Lovat, P; Lunec, J; Mahdi, AK; Wang, N; Wu, CE1
Chen, J; Cheng, C; He, MX; Yang, D; Yang, JM; Zhang, WP1
Che, Y; Ding, X; Song, J; Sun, X; Xu, L; Zhang, X1
Wang, Q; Weisberg, E; Zhao, JJ1
Blank, C; Cornelissen-Steijger, PD; Geukes Foppen, MH; Goding, CR; Graeber, TG; Haanen, J; Hugo, W; Kemper, K; Kong, X; Krijgsman, O; Lo, RS; McDermott, U; Müller, J; Peeper, DS; Possik, PA; Ribas, A; Robert, L; Song, C; Tsoi, J1
Dong, M; Fan, Y; Feng, J; Hong, X; Huang, H; Ke, X; Li, W; Lu, X; Ning, Z; Qi, J; Shen, Z; Shi, Y; Yu, L; Zhang, W; Zhao, X; Zhou, D; Zhu, J1
Miele, L; Morello, S; Pinto, A; Porta, A; Sorrentino, C1
Anderton, SM; Brunton, VG; Byron, A; Canel, M; Frame, MC; Gilbert, N; Gómez-Cuadrado, L; Lund, T; Maniati, E; McPherson, RC; Muir, M; Nibbs, RJ; Pachter, JA; Ring, JE; Serrels, A; Serrels, B; Sims, AH; von Kriegsheim, A1
Geisslinger, G; King-Himmelreich, TS; Laarmann, K; Meissner, M; Möser, CV; Niederberger, E; Olbrich, K; Wolters, MC1

Trials

1 trial(s) available for alpha-aminopyridine and Skin Neoplasms

ArticleYear
Results from a multicenter, open-label, pivotal phase II study of chidamide in relapsed or refractory peripheral T-cell lymphoma.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2015, Volume: 26, Issue:8

    Topics: Adult; Aged; Aminopyridines; Antineoplastic Agents; Benzamides; Disease-Free Survival; Enteropathy-Associated T-Cell Lymphoma; Female; Histone Deacetylase Inhibitors; Humans; Leukopenia; Lymphoma, Extranodal NK-T-Cell; Lymphoma, Large-Cell, Anaplastic; Lymphoma, T-Cell, Cutaneous; Lymphoma, T-Cell, Peripheral; Male; Middle Aged; Mycosis Fungoides; Neoplasm Recurrence, Local; Neutropenia; Skin Neoplasms; Thrombocytopenia; Treatment Outcome; Young Adult

2015

Other Studies

15 other study(ies) available for alpha-aminopyridine and Skin Neoplasms

ArticleYear
[Long-term remission of a patient with Sézary syndrome treated with chidamide combined with PD-1 blockade: a case report].
    Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi, 2022, 02-14, Volume: 43, Issue:2

    Topics: Aminopyridines; Benzamides; Humans; Programmed Cell Death 1 Receptor; Sezary Syndrome; Skin Neoplasms

2022
Case report: response to the ERK1/2 inhibitor ulixertinib in BRAF D594G cutaneous melanoma.
    Melanoma research, 2022, 08-01, Volume: 32, Issue:4

    Topics: Aminopyridines; Cell Line, Tumor; Humans; MAP Kinase Signaling System; Melanoma; Melanoma, Cutaneous Malignant; Mitogen-Activated Protein Kinase Kinases; Mutation; Protein Kinase Inhibitors; Proto-Oncogene Proteins B-raf; Pyrroles; Skin Neoplasms

2022
Effective Treatment of Metastatic Melanoma by Combining MAPK and PI3K Signaling Pathway Inhibitors.
    International journal of molecular sciences, 2019, Aug-29, Volume: 20, Issue:17

    Topics: Aminopyridines; Animals; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cell Line, Tumor; Melanoma; Mice, Inbred NOD; Mice, SCID; Mitogen-Activated Protein Kinases; Morpholines; Phosphatidylinositol 3-Kinases; Protein Kinase Inhibitors; Pyridones; Pyrimidinones; Signal Transduction; Skin Neoplasms; Treatment Outcome; Tumor Burden; Xenograft Model Antitumor Assays

2019
PLX3397 inhibits the accumulation of intra-tumoral macrophages and improves bromodomain and extra-terminal inhibitor efficacy in melanoma.
    Pigment cell & melanoma research, 2020, Volume: 33, Issue:2

    Topics: Aminopyridines; Animals; Cell Line, Tumor; Cell Proliferation; Macrophages; Male; Melanoma; Mice, Inbred C57BL; Proteins; Proto-Oncogene Proteins B-raf; Pyrroles; Receptors, Granulocyte-Macrophage Colony-Stimulating Factor; Skin Neoplasms; Treatment Outcome

2020
E2F1/IGF-1R Loop Contributes to BRAF Inhibitor Resistance in Melanoma.
    The Journal of investigative dermatology, 2020, Volume: 140, Issue:6

    Topics: Aminopyridines; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Cell Line, Tumor; Drug Resistance, Neoplasm; E2F1 Transcription Factor; Feedback, Physiological; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Humans; Hydroxyquinolines; Melanoma; Promoter Regions, Genetic; Protein Kinase Inhibitors; Proto-Oncogene Proteins B-raf; Receptor, IGF Type 1; Skin; Skin Neoplasms

2020
Cutaneous T-Cell Lymphoma PDX Drug Screening Platform Identifies Cooperation between Inhibitions of PI3Kα/δ and HDAC.
    The Journal of investigative dermatology, 2021, Volume: 141, Issue:2

    Topics: Aminopyridines; Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Circulating Tumor DNA; Class I Phosphatidylinositol 3-Kinases; Drug Synergism; Female; Gene Knockdown Techniques; High-Throughput Screening Assays; Histone Deacetylase Inhibitors; Histone Deacetylases; Humans; Lymphoma, T-Cell, Cutaneous; Mice; Morpholines; Protein Kinase Inhibitors; Skin; Skin Neoplasms; Tumor Burden; Xenograft Model Antitumor Assays

2021
An exploratory open-label, investigator-initiated study to evaluate the efficacy and safety of combination sonidegib and buparlisib for advanced basal cell carcinomas.
    Journal of the American Academy of Dermatology, 2018, Volume: 78, Issue:5

    Topics: Aged; Aged, 80 and over; Aminopyridines; Antineoplastic Combined Chemotherapy Protocols; Biphenyl Compounds; Carcinoma, Basal Cell; Cohort Studies; Disease-Free Survival; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Male; Maximum Tolerated Dose; Middle Aged; Morpholines; Neoplasm Invasiveness; Neoplasm Staging; Prognosis; Prospective Studies; Pyridines; Skin Neoplasms; Survival Analysis; Treatment Outcome

2018
Targeting negative regulation of p53 by MDM2 and WIP1 as a therapeutic strategy in cutaneous melanoma.
    British journal of cancer, 2018, 02-20, Volume: 118, Issue:4

    Topics: Aminopyridines; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dipeptides; Drug Synergism; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Imidazoles; Melanoma; Melanoma, Cutaneous Malignant; Mutagenesis, Site-Directed; para-Aminobenzoates; Phosphorylation; Piperazines; Protein Binding; Protein Phosphatase 2C; Protein Stability; Proto-Oncogene Proteins c-mdm2; Pyrrolidines; Skin Neoplasms; Tumor Suppressor Protein p53

2018
Secondary skin involvement in gastric diffuse large B-cell lymphoma treated with chidamide: A case report.
    Medicine, 2018, Volume: 97, Issue:49

    Topics: Aminopyridines; Antineoplastic Agents; Benzamides; Diagnosis, Differential; Humans; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Middle Aged; Skin Neoplasms; Stomach Neoplasms

2018
Effective remission of chidamide on treatment of advanced mycosis fungoides: An unusual case report.
    Dermatologic therapy, 2019, Volume: 32, Issue:4

    Topics: Adult; Aminopyridines; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Cisplatin; Cyclophosphamide; Etoposide; Female; Humans; Mycosis Fungoides; Quality of Life; Skin Neoplasms; Treatment Outcome; Vincristine

2019
The gene dosage of class Ia PI3K dictates the development of PTEN hamartoma tumor syndrome.
    Cell cycle (Georgetown, Tex.), 2013, Dec-01, Volume: 12, Issue:23

    Topics: Alleles; Aminopyridines; Animals; Breast Neoplasms; Class Ia Phosphatidylinositol 3-Kinase; Disease Models, Animal; Female; Gene Dosage; Genotype; Hamartoma Syndrome, Multiple; Mice; Morpholines; Phosphoinositide-3 Kinase Inhibitors; Proto-Oncogene Proteins c-akt; PTEN Phosphohydrolase; Skin Neoplasms

2013
Low MITF/AXL ratio predicts early resistance to multiple targeted drugs in melanoma.
    Nature communications, 2014, Dec-15, Volume: 5

    Topics: Aminopyridines; Animals; Antineoplastic Agents; Axl Receptor Tyrosine Kinase; Benzamides; Cell Line, Tumor; Drug Resistance, Neoplasm; Extracellular Signal-Regulated MAP Kinases; Gene Expression Regulation, Neoplastic; Humans; Imatinib Mesylate; Imidazoles; Indoles; Melanoma; Mice; Microphthalmia-Associated Transcription Factor; Oximes; Piperazines; Prognosis; Protein Kinase Inhibitors; Proto-Oncogene Proteins; Proto-Oncogene Proteins B-raf; Pyridones; Pyrimidines; Pyrimidinones; Receptor Protein-Tyrosine Kinases; Signal Transduction; Skin Neoplasms; Sulfonamides; Vemurafenib; Xenograft Model Antitumor Assays

2014
Myeloid-derived suppressor cells contribute to A2B adenosine receptor-induced VEGF production and angiogenesis in a mouse melanoma model.
    Oncotarget, 2015, Sep-29, Volume: 6, Issue:29

    Topics: Aminopyridines; Angiogenesis Inducing Agents; Angiogenesis Inhibitors; Animals; Antigens, Ly; CD11b Antigen; Disease Models, Animal; Female; Flow Cytometry; Melanoma; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Myeloid Cells; Neovascularization, Pathologic; Receptor, Adenosine A2B; Skin Neoplasms; T-Lymphocytes; Tumor Microenvironment; Vascular Endothelial Growth Factor A

2015
Nuclear FAK controls chemokine transcription, Tregs, and evasion of anti-tumor immunity.
    Cell, 2015, Sep-24, Volume: 163, Issue:1

    Topics: Aminopyridines; Animals; Carcinoma, Squamous Cell; Chemokine CCL5; Disease Models, Animal; Focal Adhesion Protein-Tyrosine Kinases; Humans; Keratinocytes; Mice; Mice, Nude; Skin Neoplasms; T-Lymphocytes, Regulatory; Transcription, Genetic; Tumor Escape

2015
The protein kinase IKKepsilon contributes to tumour growth and tumour pain in a melanoma model.
    Biochemical pharmacology, 2016, Mar-01, Volume: 103

    Topics: Aminopyridines; Animals; Cell Cycle; Cell Line; Cell Line, Tumor; Cell Proliferation; Humans; I-kappa B Kinase; Melanocytes; Melanoma; Melanoma, Experimental; Mice, Inbred C57BL; Mice, Knockout; Pain; Skin Neoplasms

2016